Streetbeat News

Analyst Ratings

GKOS

SGHT

Needham expects Glaukos Corp (GKOS) to surpass expectations and raise its Q2 FY23 outlook, driven by rebounding iStent inject volumes and the accelerating iAccess and iPRIME launches. The analyst firm maintains a Buy rating and raises the price target to $89 from $67. Glaukos could see increasing iStent momentum before favorable ASC facility fee changes in 2024. The changes could potentially drive $10 million in revenue to GKOS in 2024.

Portfolio Pulse from Vandana Singh

July 19, 2023 | 6:26 pm

PII

Citigroup analyst James Hardiman maintains a Neutral rating on Polaris (NYSE:PII) and raises the price target from $108 to $130.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 6:21 pm

C

PPG

Citigroup analyst Patrick Cunningham maintains a Buy rating on PPG Industries (NYSE:PPG) and raises the price target from $161 to $174.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 6:18 pm

CVX

A significant investor has taken a bearish stance on Chevron (NYSE:CVX), with 54% of investors opening trades with bearish expectations. The whales have been targeting a price range from $150.0 to $185.0 for Chevron over the last 3 months. The price of CVX is up 0.62% at $154.7. Citigroup, Raymond James, Mizuho, and Morgan Stanley have maintained their ratings on Chevron with price targets of $170, $200, $205, and $197 respectively.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 6:15 pm

MRNA

A whale investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 80% of the spotted trades being bearish. The whales have been targeting a price range from $90.0 to $135.0 for Moderna over the last 3 months. HSBC has downgraded its action to Reduce with a price target of $97, while UBS upgraded its action to Buy with a price target of $191. Morgan Stanley has maintained their Equal-Weight rating on Moderna, with a price target of $128.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 6:15 pm

ENPH

A significant amount of unusual options activity has been detected for Enphase Energy (NASDAQ:ENPH), with a bearish stance being taken by a majority of investors. Whales have been targeting a price range from $125.0 to $490.0 for Enphase Energy over the last 3 months. The company's stock price is currently up 0.75% at $185.43. Analysts from Barclays, Oppenheimer, Goldman Sachs, Truist Securities, and B. Riley Securities have provided their ratings and price targets for the company.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 6:15 pm

SHW

Citigroup analyst Patrick Cunningham maintains a Buy rating on Sherwin-Williams (NYSE:SHW) and raises the price target from $283 to $310.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 6:14 pm

STZ

Morgan Stanley analyst Dara Mohsenian reiterated an Overweight rating on Constellation Brands Inc (STZ) with a price target of $290. The company has entered into an information-sharing agreement with Elliott Investment Management L.P. and appointed two new independent directors. The analyst believes the collaboration with Elliott could accelerate the re-rating and increase the probability of a short-term bull-case for STZ. The agreement is seen as a step to improve governance and distance the company from its historical poor capital allocation.

Portfolio Pulse from Shivani Kumaresan

July 19, 2023 | 6:13 pm

HWC

Hancock Whitney Corp (HWC) received mixed analyst opinions following its Q2 results. Truist Securities and Stephens & Co. raised the price target to $47, while Raymond James increased it to $46. However, Truist and Stephens lowered the EPS estimates for 2023 and 2024, citing expected lower revenue and higher expenses. Piper Sandler reduced the price target to $46 and downgraded the rating to Neutral.

Portfolio Pulse from Lekha Gupta

July 19, 2023 | 6:11 pm

SPLK

BMO Capital and Truist analysts have reiterated their Buy ratings on Splunk Inc (NASDAQ:SPLK), with price targets of $117.00 and $130.00 respectively. The analysts highlighted the improved integration of Splunk's observability solution and the launch of the Splunk AI assistant. Despite pricing frustrations, all companies renewed with Splunk. The company's multiple growth levers, operational efficiencies, and upcoming renewal conversations provide expansion opportunities.

Portfolio Pulse from Anusuya Lahiri

July 19, 2023 | 6:11 pm